# GE HealthCare Technologies Inc. – Consensus ‘buy’ rating and 24.5% Upside Potential

- Link: https://www.directorstalkinterviews.com/ge-healthcare-technologies-inc.consensus-buy-rating-and-24.5-upside-potential/4121132295
- Published: 2023-11-09T12:50:38+00:00
- Author: Charlotte Edwards

**GE HealthCare Technologies Inc.** with ticker code (GEHC) have now 10 analysts
in total covering the stock. The consensus rating is pointing to ‘buy’. The target
price High/Low ranges between $99.00 and $78.00 suggesting an average Analsyt target
price of $88.00. Now with the previous closing price of $70.70 this is indicating
there is a potential upside of 24.5%. The day 50 moving average is $66.89 and the
200 day moving average is $74.45. The company has a market cap of 31.86B. The stock
price for the company is currently is currently $69.99 USD

 The potential market cap would be $39,659,068,687 based on the market consensus.

The company has a dividend yield of 0.77%. Other points of data to note are a P/
E ratio of 20.77, revenue per share of $42.36 and a 6.17% return on assets.

GE HealthCare Technologies Inc. is a global medical technology, pharmaceutical diagnostics,
and digital solutions company. The Company develops, manufactures, and markets a
portfolio of products, services, and complementary digital solutions used in the
diagnosis, treatment, and monitoring of patients. The Company’s segments include
Imaging, Ultrasound, Patient Care Solutions and Pharmaceutical Diagnostics. The 
Imaging segment includes scanning devices, clinical applications, service capabilities
and digital solutions. The Ultrasound segment includes screening, diagnosis, treatment,
and monitoring of certain diseases. The Patient Care Solutions segment includes 
medical devices, services, consumable products, services, and digital solutions.
The Pharmaceutical Diagnostics segment is a supplier of diagnostic agents to the
global radiology and nuclear medicine industry.

Share on: